Oct 2018 $5 M No. 8 $2 to $10 million 4
Myoscience Inc.: Raise no. 8, Oct 2018 × Investors in this round 4 investors had bought by the notice of Nov 13, 2018: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Sam Mawn-Mahlau · Executive Officer · Assistant Corporate Secretary Timothy Still · Executive Officer, Director · CEO Anthony Lando · Director Bernard Coulie · Director Brian Farley · Director Darnard Guillaume · Director Jan Pansaert · Director Jon Serbousek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Multiple Closings”Signed by Sam Mawn-Mahlau, Assistant Corporate Secretary. Source: SEC Form D, newest notice filed Nov 13, 2018. Read the notice at the SEC .
debt, options SEC Mar 2018 $31 M No. 7 $10 to $50 million 17
Myoscience Inc.: Raise no. 7, Mar 2018 × Investors in this round 17 investors had bought by the notice of Mar 7, 2018: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $31 M of $41 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cary Vance · Executive Officer, Director · CEO John Supan · Executive Officer · CFO Sam Mawn-Mahlau · Executive Officer · Assistant Corporate Secretary Anthony Lando · Director Bernard Coulie · Director Guillaume Darnard · Director Jan Pensaert · Director Jon Serbousek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Payment in part by cancellation of indebtedness”Signed by Sam Mawn-Mahlau, Assistant Corporate Secretary. Source: SEC Form D, newest notice filed Mar 7, 2018. Read the notice at the SEC .
equity, options SEC Nov 2016 $14 M No. 6 $10 to $50 million 2
Myoscience Inc.: Raise no. 6, Nov 2016 × Investors in this round 2 investors had bought by the notice of Oct 18, 2017: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $21 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cary Vance · Executive Officer · CEO Sam Mawn-Mahlau · Executive Officer · Assistant Corporate Secretary Anthony Lando · Director Bernard Coulie · Director Guillaume Darnard · Director Jan Pensaert · Director Jon Serbousek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amount was increased from $10,000,000 to $21,000,000”Signed by Sam Mawn-Mahlau, Assistant Secretary. Source: SEC Form D and 1 amendment, newest notice filed Oct 18, 2017. Read the notice at the SEC .
equity SEC Jul 2014 $8 M No. 5 $2 to $10 million 28
Myoscience Inc.: Raise no. 5, Jul 2014 × Investors in this round 28 investors had bought by the notice of Sep 26, 2014: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $12 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jeffrey M. Gold · Executive Officer Jesse D. Rosen · Executive Officer John M. Allison · Executive Officer Justin M. Chickles · Executive Officer Peter M. Osborne · Executive Officer Richard M. Ferrari · Executive Officer, Director Tracy M. Henry · Executive Officer Edwin D. Snape · Director James M. Hawkins · Director Remmert M. Laan · Director Rudi M. Marien · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard M. Ferrari, Interim CEO. Source: SEC Form D, newest notice filed Sep 26, 2014. Read the notice at the SEC .
debt, options SEC Sep 2013 $10 M No. 4 $10 to $50 million 35
Myoscience Inc.: Raise no. 4, Sep 2013 × Investors in this round 35 investors had bought by the notice of Oct 9, 2013: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $25 M offered; $15 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill Brodie · Executive Officer Clint Carnell · Executive Officer, Director John Allison · Executive Officer Peter M. Osborne · Executive Officer Tracy M. Henry · Executive Officer Edwin M. Snape · Director Remmert M. Laan · Director Richard M. Ferrari · Director Rudi M. Marien · Director Thomas D. Weldon · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Osborne, Secretary. Source: SEC Form D, newest notice filed Oct 9, 2013. Read the notice at the SEC .
equity SEC Mar 2012 $33 M No. 3 $10 to $50 million 32
Myoscience Inc.: Raise no. 3, Mar 2012 × Investors in this round 32 investors had bought by the notice of Apr 2, 2012: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $33 M of $45 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $643,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks finders' fees as estimates
The company Corporation, incorporated in Delaware People named in the notice Clint Carnell · Executive Officer, Director Robert Grant · Executive Officer, Director Edwin Snape · Director Jeffrey Nugent · Director Joe Whitters · Director Lisa Elkins · Director Richard Ferrari · Director Thomas Weldon · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round American Equities Overseas, Inc. · Zurich, Switzerland Sold in no state named, and outside the US Remarks in the notice On fees: “This amount is an estimate, and does not include reasonable out-of-pockets expenses which will also be reimbursed. Of the fee mentioned herein, roughly half will be paid in cash and roughly half will be issued in the form of warrants.”On the amounts: “The actual total offering amount: $44,999,999.76”Signed by Clint Carnell, Ceo. Source: SEC Form D, newest notice filed Apr 2, 2012. Read the notice at the SEC .
equity SEC Mar 2011 $19 M No. 2 $10 to $50 million 35
Myoscience Inc.: Raise no. 2, Mar 2011 × Investors in this round 35 investors had bought by the notice of Mar 16, 2011: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $19 M of $26 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kristine M. Tatsutani · Executive Officer Matthew M. Franklin · Executive Officer Mike M. Fourkas · Executive Officer Robert M. Curtis · Executive Officer, Director Jeffrey M. Nugent · Director Joe M. Whitters · Director Lisa M. Elkins · Director Richard M. Ferrari · Director Robert M. Grant · Director Thomas E. Hancock · Director Thomas M. Weldon · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount: $26,160,000.00 Total Amount Sold: $18,758,617.20 Total Remaining to be Sold: $7,401,382.80”Signed by Robert M. Curtis, President & CEO. Source: SEC Form D, newest notice filed Mar 16, 2011. Read the notice at the SEC .
equity SEC Aug 2010 $2 M No. 1 $2 to $10 million 8
Myoscience Inc.: Raise no. 1, Aug 2010 × Investors in this round 8 investors had bought by the notice of Aug 30, 2010: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kristine M. Tatsutani · Executive Officer Matthew M. Franklin · Executive Officer Mike M. Fourkas · Executive Officer Robert M. Curtis · Executive Officer, Director Jeffrey M. Nugent · Director Joe M. Whitters · Director John M. Deedrick · Director Lisa M. Elkins · Director Richard M. Ferrari · Director Thomas E. Hancock · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount: $3,000,000.00; Total Amount Sold: $2,199,975.18; Total Remaining to be Sold: $800,024.82”Signed by Robert M. Curtis, President & CEO. Source: SEC Form D, newest notice filed Aug 30, 2010. Read the notice at the SEC .
debt, options SEC